Brain health and cognitive and mood disorders in ageing women

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 27, Issue 5, 2013, Pages 661-672

  Silva, Ivaldo ^a   Naftolin, Frederick ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NEW YORK UNIVERSITY   (United States)

Author keywords

aging; bain; cognition; hormone; sexual; woman

Indexed keywords

ESTROGEN; SEX HORMONE;

AGING; ARTICLE; BRAIN CELL; BRAIN FUNCTION; COGNITION; DEMENTIA; DEPRESSION; MENOPAUSE; MOOD DISORDER; PRIORITY JOURNAL; QUALITY OF LIFE; SLEEP QUALITY;

AGING; BAIN; COGNITION; SEXUAL HORMONE; WOMAN;

AGING; BRAIN; COGNITION DISORDERS; DEMENTIA; DEPRESSIVE DISORDER; ESTROGENS; FEMALE; HUMANS; MENOPAUSE; MOOD DISORDERS; SLEEP;

EID: 84883888232     PISSN: 15216934     EISSN: 15321932     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2013.06.005     Document Type: Article

References (72)

1. D.C. Brown, M.D. Hayward, and J.K. Montez The significance of education for mortality compression in the United States Demography 49 2012 819 840
2. R. Pollycove, F. Naftolin, and J.A. Simon The evolutionary origin and significance of menopause Menopause 18 2011 336 342
3. T.R. Patel Environmental enrichment: aging and memory Yale J Biol Med 85 2012 491 500
4. C. Glorioso, and E. Sibille Between destiny and disease: genetics and molecular pathway of human central nervous system aging Prog Neurobiol 93 2011 165 181
5. I. Silva, G. Mor, and F. Naftolin Estrogen and the aging brain Maturitas 38 2001 95 100
6. L. Puelles Contributions to neuroembryology of Santiago Ramon y Cajal (1852-1934) and Jorge F. Tello (1880-1958) Int J Dev Biol 53 2009 1145 1160
7. F. Naftolin, L.M. Garcia-Segura, and D. Keefe Estrogen effects on the synaptology and neural membranes of the rat hypothalamic arcuate nucleus Biol Reprod 42 1990 21 28
8. F. Naftolin, L.M. Garcia-Segura, and T.L. Horvath Estrogen-induced hypothalamic synaptic plasticity and pituitary sensitization in the control of the estrogen-induced gonadotrophin surge Reprod Sci 14 2007 101 116
9. B.S. McEwen How do sex and stress hormones affect nerve cells? Ann NY Acad Sci 743 1994 1 18
10. D.L. Keefe, D.S. Michelson, and S.H. Lee Astrocytes within the hypothalamic arcuate nucleus contain estrogen-sensitive peroxidase, bind fluorescein-conjugated estradiol, and may mediate synaptic plasticity in the rat Am J Obstet Gynecol 164 1991 959 966
11. A. Grimm, Y.A. Lim, and A.G. Mensah-Nyagan Alzheimer's disease, oestrogen and mitochondria: an ambiguous relationship Mol Neurobiol 46 2012 151 160
12. M. Alvarez-DE-LA-Rosa, I. Silva, and J. Nilsen Estradiol prevents neural tau hyperphosphorylation characteristic of Alzheimer's disease Ann NY Acad Sci 1052 2005 210 224
13. T.T. Lam, and C. Leranth Gonadal hormones act extrinsic to the hippocampus to influence the density of hippocampal astroglial processes Neuroscience 116 2003 491 498
14. M.C. Haigis, and B.A. Yankner The aging stress response Mol Cell 40 2010 333 344
15. A.J. Eisch, and D. Petrik Depression and hippocampal neurogenesis: a road to remission? Science 338 2012 72 75
16. N. Bolandzadeh, J.C. Davis, and R. Tam The association between cognitive function and white matter lesion location in older adults: a systematic review BMC Neurol 30 2012 12
17. Y. Wu, D. Zhang, and Z. Pang Gender-specific patterns in age-related decline in general health among Danish and Chinese: a cross-national comparative study Geriatr Gerontol Int 12 2012 431 439
18. G.A. Greendale, C.A. Derby, and P.M. Maki Perimenopause and cognition Obstet Gynecol Clin North Am 30 2011 519 535
19. P.M. Maki Potential importance of early initiation of hormone therapy for cognitive benefit Menopause 13 2006 6 7
20. M.C. Craig, P.M. Maki, and D.G. Murphy The Women's Health Initiative Memory Study: findings and implications for treatment Lancet Neurol 4 2005 190 194
21. S.M. Resnick, and P.M. Maki Effects of hormone replacement therapy on cognitive and brain aging Ann NY Acad Sci 949 2001 203 214
22. Alzheimer's Association Reports: 2011 Alzheimer's disease facts and figures W V Med J 107 2011 82 83
23. K. Honjo, S.E. Black, and N.P. Verhoeff Alzheimer's disease, cerebrovascular disease and the β-amyloid cascade Can J Neurol Sci 39 2012 712 728
24. P. Dunkel, C.L. Chai, and B. Sperlágh Clinical utility of neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis Expert Opin Investig Drug 21 2012 1267 1308
25. A. Cherubini, D.T. Lowenthal, and E. Paran Hypertension and cognitive function in the elderly Dis Mon 56 2010 106 147
26. I. Bechmann, G. Mor, and Nilsen FasL (CD95L, Apo1L) is expressed in the normal rat and human brain-evidence for the existence of an immunological brain barrier Glia 27 1999 62 74
27. G. Mor, J. Nilsen, and T. Horvath Estrogen and microglia: a regulatory system that affects the brain J Neurobiol 40 1999 484 496
28. I. Bechmann, J. Goldmann, and A.D. Kovac Circulating monocytic cells infiltrate layers of anterograde axonal degeneration where they transform into microglia FASEB J 19 2005 647 649
29. C. Annweiler, O. Beauchet, S. Celle WALK Team (Working group Angers-London for Knowledge) Contribution of brain imaging to the understanding of gait disorders in Alzheimer's disease: a systematic review Am J Alzheimers Dis Other Demen 27 2012 371 380
30. Y. Liang, N.S. Ryan, and J.M. Schott Imaging the onset and progression of Alzheimer's disease: implications for prevention trials J Alzheimer Dise (Suppl) 1 2013 S305 S312
31. A. Wimo, and M. Prince World Alzheimer report 2011: the global economic impact of dementia 2010 Alzheimer's Disease International
32. B.A. Yankner, T. Lu, and P. Loerch The aging brain Ann Rev Pathol 3 2008 41 66
33. N. Bhattarai, J. Charlton, and C. Rudisill Prevalence of depression and utilization of health care in single and multiple morbidity: a population-based cohort study Psychol Med 1 2012 1 9
34. M.M. Fässberg, S. Ostling, and A. Börjesson-Hanson Suicidal feelings in the twilight of life: a cross-sectional population-based study of 97-year-olds BMJ 1 2013 3
35. J.M. Cyranowski, L.L. Schott, and H.M. Kravitz Psychosocial features associated with lifetime comorbidity of major depression and anxiety disorders among a community sample of mid-life women: the SWAN mental health study Depress Anxiety 29 2012 1050 1057
36. F. Artigas Serotonin receptors involved in antidepressant effects Pharmacol Ther 137 2013 119 131
37. A. Höflich, P. Baldinger, and M. Savli Imaging treatment effects in depression Rev Neurosci 23 2012 227 252
38. H. Joffe, K.A. Guthrie, and J. Larson Relapse of vasomotor symptoms after discontinuation of the selective serotonin reuptake inhibitor escitalopram: results from the Menopause Strategies: finding lasting answers for symptoms and health research network Menopause 20 3 2012 261 268
39. J.W. Simpkins, and M. Singh More than a decade of estrogen neuroprotection Alzheimers Dement 4 2008 S131 S136
40. S. Merlo, and M.A. Sortino Estrogen activates matrix metalloproteinases-2 and -9 to increase beta amyloid degradation Mol Cell Neurosci 49 2012 423 429
41. F. Naftolin, K.J. Ryan, and I.J. Davies The formation of estrogens by central neuroendocrine tissues Recent Prog Horm Res 31 1975 295 319
42. L.D. McCullough, and P.D. Hurn Estrogen and ischemic neuroprotection: an integrated view Trend Endocrinol Metab 14 2003 228 235
43. F. Naftolin Sex steroids and the brain Gynecol Endocrinol 24 2008 533 534
44. S.H. Barsom, P.K. Mansfield, and P.B. Koch Association between psychological stress and menstrual cycle characteristics in perimenopausal women Womens Health Issues 14 2004 235 241
45. S.M. Resnick, J. Sojkova, and Y. Zhou Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB Neurology 74 2010 807 815
46. M.A. Rapp, M. Schnaider-Beeri, and D.P. Purohit Increased neurofibrillary tangles in patients with Alzheimer disease with comorbid depression Am J Geriatr Psychiatry 16 2008 168 174
47. N. Levy-Cooperman, A.M. Burhan, and S. Rafi-Tari Frontal lobe hypoperfusion and depressive symptoms in Alzheimer disease J Psychiatry Neurosci 33 2008 218 226
48. J.T. O'Brien, M.J. Firbank, M.S. Krishnan LADIS Group White matter hyperintensities rather than lacunar infarcts are associated with depressive symptoms in older people: the LADIS study Am J Geriatr Psychiatry 14 2006 834 841
49. D.C. Steffens, G.G. Potter, and D.R. McQuoid Longitudinal magnetic resonance imaging vascular changes, apolipoprotein E genotype, and development of dementia in the neurocognitive outcomes of depression in the elderly study Am J Geriatr Psychiatry 15 2007 839 849
50. I. Silva, L.E. Mello, and E. Freymüller Estrogen, progestogen and tamoxifen increase synaptic density of the hippocampus of ovariectomized rats. Of CA1 hippocampus in ovariectomized adult rats Neurosci Lett 291 2000 183 186
51. I. Azcoitia, A. Sierra, and S. Veiga Aromatase expression by reactive astroglia is neuroprotective Ann NY Acad Sci 1007 2003 298 305
52. C.S. Woolley, N.G. Weiland, and B.S. McEwen Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: correlation with dendritic spine density J Neurosci 17 1997 1848 1859
53. E.E. Baulieu, and P. Robel Dehydroepiandrosterone and dehydroepiandrosterone sulfate as neuroactive neurosteroids J Endocrinol 150 1996 S221 S239
54. G. Mor, E. Sapi, and V.M. Abrahams Interaction of the estrogen receptors with the Fas ligand promoter in human monocytes J Immunol 170 2003 114 122
55. J. Nilsen, G. Mor, and F. Naftolin Estrogen-regulated developmental neuronal apoptosis is determined by estrogen receptor subtype and the Fas/Fas ligand system J Neurobiol 43 2000 64 78
56. H. Honjo, K. Iwasa, and M. Kawata Progestins and estrogens and Alzheimer's disease J Steroid Biochem Mol Biol 93 2005 305 308
57. D.L. Keefe, R. Watson, and F. Naftolin Hormone replacement therapy may alleviate sleep apnea in menopausal women: a pilot study Menopause 6 1999 196 200
58. F. Guidozzi Sleep and sleep disorders in menopause women Climacteric 16 2013 214 219
59. J. Studd, and R.E. Nappi Reproductive depression Gynecol Endocrinol 28 2012 42 45
60. E.W. Freeman, M.D. Samuel, and H. Lin Temporal associations of hot flashes and depression in the transition to menopause Menopause 16 2009 728 734
61. M.A. Espeland, S.R. Rapp, S.A. Shumaker Women's Health Initiative Memory Study Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study JAMA 291 2004 2959 2968
62. S. Recamier-Carballo, E. Estrada-Camarena, and R. Reyes Synergistic effect of estradiol and fluoxetine in Young adult and middle-aged female rats in two models of experimental depression Behav Brain Res 233 2012 351 358
63. J.L. Spencer, E.M. Waters, and R.D. Romeo Uncovering the mechanisms of estrogen effects on hippocampal function Front Neuroendocrinol 29 2008 219 237
64. S. Mosselman, J. Polman, and R. Dijkema ER beta: identification and characterization of a novel human estrogen receptor FEBS Lett 392 1996 49 53
65. N. Pluchino, A.D. Genazzani, and F. Bernardi Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels Gynecol Endocrinol 20 2005 144 149
66. V.W. Henderson, and B.B. Sherwin Surgical versus natural menopause: cognitive issues Menopause 14 2007 572 579
67. P.J. Schmidt, P.A. Keenan, and L.A. Schenkel Cognitive performance in healthy women during induced hypogonadism and ovarian steroid addback Arch Womens Mental Health 16 2013 47 58
68. P.M. Maki Minireview: effects of different HT formulations on cognition Endocrinology 153 2012 3564 3570
69. S. Asthana, R.D. Brinton, V.W. Henderson Frontiers Proposal for Estrogen Work Group; Cognitive Aging Work Group Frontiers proposal. National Institute on Aging "bench to bedside: estrogen as a case study" Age (Dordr) 31 2009 199 210
70. W. Wharton, C.E. Gleason, V.M. Miller, and S. Asthana Rationale and design of the Kronos Early Estrogen Prevention Study (KEEPS) and the KEEPS Cognitive and Affective sub study (KEEPS Cog) Brain Res 1514 2013 12 17
71. B. Cholerton, C.E. Gleason, and L.D. Baker Estrogen and Alzheimer's disease: the story so far Drugs Aging 19 2002 405 427
72. K. Agrawal, S. Onami, and J.E. Mortimer Cognitive changes associated with endocrine therapy for breast cancer Maturitas 67 2010 209 214